| Application no. and date | 03721414.5 (espacenet) (Federated) (European Patent Register), 20030320 | | Patent/reg. no. and date | DK/EP 1485087, 20090826 | | Publication date | 20041215 | | Priority no. and date | US 366515 P, 20020320, US 438450 P, 20030107 | | EP pub. no. and date |
EP 1485087 20041215 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 86 Morris Avenue
Summit, New Jersey 07901, US | | Applicant ref. no. | 136701 | | Inventor | Man, Hon-wah, 27 Grant Way
Princeton, NJ 08540, US,
GE, Chuansheng, 9 Breckenridge Court
Belle Mead, NJ 08502, US,
SCHAFER, Peter, H., 126 John E. Busch Avenue
Somerset, NJ 08873, US,
MULLER, George, W., P.O. Box 3688
Rancho Santa Fe,
CA 92067, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61P 35/00 (2006.01) , C07C 317/28 (2006.01) , C07D 209/48 (2006.01) | | Title | (+)-2[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion til anvendelse ved behandling af psoriasis ved oral indgivelse | | Int. application no. | US2003008738 | | Int. publication no. | WO2003080049 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
